Invest Like The Best
Episode 130 The Tech Imperative
Invest Like The Best

Episode 130: The Tech Imperative

Invest Like The Best

Episode 130

The Tech Imperative

Josh Wolfe is the co-founder and managing partner at Lux Capital. We cover the checklist Josh uses to evaluate leaders, the closing gap between sci-fi and sci-fact, and the current theses that Lux is chasing.

[00:01:22] – (First Question) – Ability to tackle massive scale problems

[00:04:05] – Key roles of leaders and his checklist for evaluating them

[00:05:55] – Common traits among founders that make them incredible storytellers and leaders

[00:10:22] – The concept of ill-liquidity

[00:14:53] – Thoughts on the types of companies going public

[00:16:41] – Most innovative business models

[00:19:14] – Advice for LP’s

[00:23:51] – Common devil

[00:25:09] – Big internal debates at his firm, starting with price discipline

[00:28:45] – The value debate internally

[00:33:34] – CRISPR from an investment standpoint

[00:36:50] – Edge cases they are looking at

[00:46:52] – How they target ideas in a single concept

[00:51:04] – New theses that they chase

[00:56:31] – Recent adventure with special operations guys

The Tech Imperative

Introduction

Patrick
My guest this week is Josh Wolfe, co-founder and managing partner at Lux Capital. I had Josh on the podcast last year, which was one of the most popular episodes in the show's history. This is a continuation of our ongoing conversation about investing in the frontiers of technology. My favorite thing about Josh and the way that he invests is the mosaic that he and his team at Lux are constantly building to understand the world and where new companies may fit in. We cover a crazy variety of topics, from business model innovation, roles of a CEO, the military, the death of privacy, and arrows of human progress. Please enjoy round two with Josh Wolfe.

Failure of Imagination

Patrick
One of the things that I'm fascinated about right now is just big coordination problems. You mentioned China specifically, which I think is part of the answer to this next question. I'm curious about your view on our ability, really, as a species to tackle massive-scale problems versus incremental innovation, optimization, efficiency gains that you see in a lot of business today and certainly in a lot of startups. How do you think about that dichotomy of massive-scale projects and our ability to tackle them, and what you want to fund?

Access the full transcript
Sign in or register to view episode transcripts.

Contact

Get in touch at help@joincollossus.com